Paper36924298
FGF/FGFR system in the central nervous system demyelinating disease: Recent progress and implications for multiple sclerosis.
Zhang Q and 4 others. CNS Neurosci Ther, 2023. Cited by 25 papers, by iCite.
Cite this record
ConductScience Library. FGF/FGFR system in the central nervous system demyelinating disease: Recent progress and implications for multiple sclerosis. Papers, record 36924298. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/36924298
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- FGF/FGFR system in the central nervous system demyelinating disease: Recent progress and implications for multiple sclerosis.
- PubMed
Topics6
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Multiple Sclerosis | Major topic |
| Animals | |
| Oligodendroglia | |
| Fibroblast Growth Factors | |
| Cell Differentiation | |
| Central Nervous System |
Source PubMed
References139
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 31298621 | Transplantation of Mesenchymal Stem Cells Overexpressing Fibroblast Growth Factor 21 Facilitates Cognitive Recovery and Enhances Neurogenesis in a Mouse Model of Traumatic Brain Injury. | J Neurotrauma | 2020 | https://conductscience.org/library/papers/31298621 | PubMed |
| 2 | 31364818 | Plasma proteome in multiple sclerosis disease progression. | Ann Clin Transl Neurol | 2019 | https://conductscience.org/library/papers/31364818 | PubMed |
| 3 | 11031111 | Characterization of a novel protein (FGFRL1) from human cartilage related to FGF receptors. | Genomics | 2000 | https://conductscience.org/library/papers/11031111 | PubMed |
| 4 | 7678656 | Differential myelinogenic capacity of specific developmental stages of the oligodendrocyte lineage upon transplantation into hypomyelinating hosts. | J Neurosci Res | 1993 | https://conductscience.org/library/papers/7678656 | PubMed |
| 5 | 29367757 | The miR-17/92 cluster is involved in the molecular etiology of the SCLL syndrome driven by the BCR-FGFR1 chimeric kinase. | Oncogene | 2018 | https://conductscience.org/library/papers/29367757 | PubMed |
| 6 | 21343885 | Reduced axonopathy and enhanced remyelination after chronic demyelination in fibroblast growth factor 2 (Fgf2)-null mice: differential detection with diffusion tensor imaging. | J Neuropathol Exp Neurol | 2011 | https://conductscience.org/library/papers/21343885 | PubMed |
| 7 | 12145409 | Fibroblast growth factors and their receptors in oligodendrocyte development: implications for demyelination and remyelination. | Dev Neurosci | 2002 | https://conductscience.org/library/papers/12145409 | PubMed |
| 8 | 2566844 | Pathogenesis of progressive multiple sclerosis. | Lancet | 1989 | https://conductscience.org/library/papers/2566844 | PubMed |
| 9 | 19409495 | Isolation of neural stem/progenitor cells by using EGF/FGF1 and FGF1B promoter-driven green fluorescence from embryonic and adult mouse brains. | Mol Cell Neurosci | 2009 | https://conductscience.org/library/papers/19409495 | PubMed |
| 10 | 20393505 | Ectopic expression of wild-type FGFR3 cooperates with MYC to accelerate development of B-cell lineage neoplasms. | Leukemia | 2010 | https://conductscience.org/library/papers/20393505 | PubMed |
| 11 | 25913734 | Fibroblast growth factor signaling in oligodendrocyte-lineage cells facilitates recovery of chronically demyelinated lesions but is redundant in acute lesions. | Glia | 2015 | https://conductscience.org/library/papers/25913734 | PubMed |
| 12 | 34593304 | FGF/FGFR signaling: From lung development to respiratory diseases. | Cytokine Growth Factor Rev | 2021 | https://conductscience.org/library/papers/34593304 | PubMed |
| 13 | 12121226 | Costimulation of T cell receptor-triggered IL-2 production by Jurkat T cells via fibroblast growth factor receptor 1 upon its engagement by CD56. | Immunol Cell Biol | 2002 | https://conductscience.org/library/papers/12121226 | PubMed |
| 14 | 16399703 | Myelin impairs CNS remyelination by inhibiting oligodendrocyte precursor cell differentiation. | J Neurosci | 2006 | https://conductscience.org/library/papers/16399703 | PubMed |
| 15 | 33802841 | FGF/FGFR Signaling in Hepatocellular Carcinoma: From Carcinogenesis to Recent Therapeutic Intervention. | Cancers (Basel) | 2021 | https://conductscience.org/library/papers/33802841 | PubMed |
| 16 | 22921867 | Fibroblast growth factor 23: state of the field and future directions. | Trends Endocrinol Metab | 2012 | https://conductscience.org/library/papers/22921867 | PubMed |
| 17 | 29890137 | Enhancement of neuronal differentiation by using small molecules modulating Nodal/Smad, Wnt/β-catenin, and FGF signaling. | Biochem Biophys Res Commun | 2018 | https://conductscience.org/library/papers/29890137 | PubMed |
| 18 | 23007702 | Progressive multiple sclerosis: pathology and pathogenesis. | Nat Rev Neurol | 2012 | https://conductscience.org/library/papers/23007702 | PubMed |
| 19 | 31382620 | The Molecular Basis for Remyelination Failure in Multiple Sclerosis. | Cells | 2019 | https://conductscience.org/library/papers/31382620 | PubMed |
| 20 | 18353554 | Fibroblast growth factor-2 levels are elevated in the cerebrospinal fluid of multiple sclerosis patients. | Neurosci Lett | 2008 | https://conductscience.org/library/papers/18353554 | PubMed |
Cited by15
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 25 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42751212 | Smoldering neuroinflammation in progressive multiple sclerosis: mechanisms, imaging biomarkers, and therapeutic opportunities. | Front Immunol | 2026 | https://conductscience.org/library/papers/42751212 | PubMed |
| 42725054 | Case Report: Post-mortem analysis of long-term inflammation after mild COVID-19. | Front Immunol | 2026 | https://conductscience.org/library/papers/42725054 | PubMed |
| 42315909 | Fibroblast growth factors in ischemic stroke: Therapeutic potential and clinical challenges. | Acta Pharmacol Sin | 2026 | https://conductscience.org/library/papers/42315909 | PubMed |
| 42158307 | Identification of diagnostic microRNAs and their target genes in multiple sclerosis based on interactome networks using an in silico approach. | Curr J Neurol | 2025 | https://conductscience.org/library/papers/42158307 | PubMed |
| 41041834 | Application potential of induced pluripotent stem cells in the research and treatment of autoimmune diseases (Review). | Mol Med Rep | 2025 | https://conductscience.org/library/papers/41041834 | PubMed |
| 40653594 | Primary Progressive Multiple Sclerosis: New Therapeutic Approaches. | Neuropsychopharmacol Rep | 2025 | https://conductscience.org/library/papers/40653594 | PubMed |
| 40410211 | Oligodendrocyte-astrocyte crosstalk in Parkinson's disease mediates neuronal ferroptosis via the FGF signaling pathway. | NPJ Parkinsons Dis | 2025 | https://conductscience.org/library/papers/40410211 | PubMed |
| 40281300 | Role of Fibroblast Growth Factors in Neurological Disorders: Insight into Therapeutic Approaches and Molecular Mechanisms. | Mol Neurobiol | 2025 | https://conductscience.org/library/papers/40281300 | PubMed |
| 40102990 | Identifying behavior regulatory leverage over mental disorders transcriptomic network hubs toward lifestyle-dependent psychiatric drugs repurposing. | Hum Genomics | 2025 | https://conductscience.org/library/papers/40102990 | PubMed |
| 39718981 | Distinct transcriptional changes distinguish efficient and poor remyelination in multiple sclerosis. | Brain | 2025 | https://conductscience.org/library/papers/39718981 | PubMed |
| 39604493 | Exploring molecular mechanisms of postoperative delirium through multi-omics strategies in plasma exosomes. | Sci Rep | 2024 | https://conductscience.org/library/papers/39604493 | PubMed |
| 39273659 | Insights into the Pathobiology of GM1 Gangliosidosis from Single-Nucleus Transcriptomic Analysis of CNS Cells in a Mouse Model. | Int J Mol Sci | 2024 | https://conductscience.org/library/papers/39273659 | PubMed |
| 38315329 | Molecular Determinants of Neurocognitive Deficits in Glioma: Based on 2021 WHO Classification. | J Mol Neurosci | 2024 | https://conductscience.org/library/papers/38315329 | PubMed |
| 37951961 | Development of synthetic modulator enabling long-term propagation and neurogenesis of human embryonic stem cell-derived neural progenitor cells. | Biol Res | 2023 | https://conductscience.org/library/papers/37951961 | PubMed |
| 36924298 | FGF/FGFR system in the central nervous system demyelinating disease: Recent progress and implications for multiple sclerosis. | CNS Neurosci Ther | 2023 | https://conductscience.org/library/papers/36924298 | PubMed |
Genes60
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/36924298
GET https://conductscience.org/api/papers/v1/36924298/references?page=2